Penumbra, Inc. (PEN)
339.36
-1.32
(-0.39%)
USD |
NYSE |
Feb 20, 16:00
339.83
+0.47
(+0.14%)
Pre-Market: 20:00
Penumbra SG&A Expense (Quarterly) : 168.90M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 1.834B |
| Intuitive Surgical, Inc. | 687.10M |
| Globus Medical, Inc. | 313.60M |
| iRhythm Holdings, Inc. | 122.00M |
| Rapt Therapeutics, Inc. | 7.337M |